According to iBio's latest financial reports the company's current revenue (TTM ) is โน32.11 Million. an increase over the revenue in the year 2023 that were of โน4.16 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | โน32.16 M | 672.86% |
2023 | โน4.16 M | -97.3% |
2022 | โน0.15 B | 54.4% |
2021 | โน99.73 M | -41.49% |
2020 | โน0.17 B | 37.08% |
2019 | โน0.12 B | 105.62% |
2018 | โน60.48 M | 106.37% |
2017 | โน29.3 M | -50.08% |
2016 | โน58.71 M | -7.87% |
2015 | โน63.73 M | -27.71% |
2014 | โน88.15 M | 131.35% |
2013 | โน38.1 M | -37.48% |
2012 | โน60.94 M | 7.25% |
2011 | โน56.82 M | |
2010 | N/A | -100% |
2009 | โน21.53 M | -63.28% |
2008 | โน58.62 M |